Rapidemic is thrilled to have been selected by TechLeap to join the third batch of quickly growing and ambitious healthtech start-ups. We look forward to a meaningful learning experience, to connect with fellow entrepreneurs and to join this national community of tech entrepreneurs.
Leiden-based startup to accelerate development of RapiDetect™ CT/NG, a power-free, ambient temperature nucleic acid...
We are happy to announce a new collaboration between Rapidemic and the Maastricht UMC+, the national reference center...
At Rapidemic, we are committed to building the next generation of diagnostics for a healthier world. We’re honored to...